Strides Arcolab Ltd (STAR.NS)
17 Dec 2014
|Market Cap (Mil.):||Rs52,965.75|
|Shares Outstanding (Mil.):||59.57|
MUMBAI - Strides Arcolab Ltd has agreed to buy smaller rival Shasun Pharmaceuticals Ltd in an all-stock deal, valued at about $200 million, to bolster its generic medicine and drug ingredient businesses.
* Deal valued at about $200 mln based on Friday closing price
MUMBAI, Sept 29 - Indian generic drugmaker Strides Arcolab Ltd said on Monday it had agreed to merge with smaller peer Shasun Pharmaceuticals Ltd in an all-stock deal.
* NSE ends 0.21 pct higher; BSE index gains 0.04 pct * Crompton Greaves jumps on demerger proposal * Mahindra and Mahindra slumps after block deals * Strides Arcolab gains; Mankekar raises stake to 4.7 pct By Abhishek Vishnoi MUMBAI, July 17 - Indian shares rose for a third straight session on Thursday as lenders such as Kotak Mahindra Bank extended gains on upbeat sentiment as the central bank exempted long-term bonds for the infrastructure sector from reserve req
(Corrects typo in company name to Strides from Stride in headline) * Shares in India's Strides Arcolab Ltd gain 2 percent after investor Shivanand Shankar Mankekar raised his stake in the company to 4.7 percent in the June quarter from 1.26 percent held earlier, according to exchange data. * Mankekar increased his share holding in the company via three entities namely, Laxmi Shivanand Mankekar, Shivanand Shankar Mankekar and Kedar Shivanand Mankekar. * Private investor Mankekar is a known stock